What investors need to know about Pfizer’s latest downgrade By: MarketWatch January 26, 2023 at 16:15 PM EST The company's pipeline, though promising, is still too premature to make up for the looming drop in COVID-19 franchise revenue. Read More >> Related Stocks: Biontech Se ADR Pfizer S&P Pharmaceuticals SPDR
